Page last updated: 2024-10-22

am 580 and Allergic Encephalomyelitis

am 580 has been researched along with Allergic Encephalomyelitis in 1 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Q1
Thome, R1
Rostami, A1
Ma, CG1
Zhang, GX1

Other Studies

1 other study available for am 580 and Allergic Encephalomyelitis

ArticleYear
The selective retinoic acid receptor-α agonist AM580 fails to control autoimmune neuroinflammation.
    Cellular & molecular immunology, 2019, Volume: 16, Issue:8

    Topics: Animals; Anti-Inflammatory Agents; Benzoates; Disease Models, Animal; Encephalomyelitis, Autoimmune,

2019